Key facts
- Doctronic’s last known valuation is $206.0M (Feb 2026).
- It has raised $65.0M; the latest was Early Stage VC ($40.0M) in Feb 2026.
- Notable investors include Lightspeed Venture Partners, Abstract Ventures, Union Square Ventures, Mantis VC, Scott Belsky — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Doctronic
- ·The full record, as it builds
Funding rounds
No funding rounds for Doctronic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Doctronic
Developer of a healthcare AI-based platform designed for real-time medical information and patient-doctor communication. The company's platform provides an AI doctor that analyzes health data and answers medical questions and offers integration with video visits with licensed doctors for prescriptions and referrals, secure storage of medical records, and continuous access to AI assistance for follow-up questions, enabling consumers to get accurate and personalized medical guidance and treatment effectively and affordably.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 4
- Website
- doctronic.ai/
- Ownership
- Privately Held (backing)
Doctronic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Doctronic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Doctronic in its N-PORT filings yet. We sweep new filings monthly.